Structure

Physi-Chem Properties

Molecular Weight:  512.19
Volume:  481.735
LogP:  0.837
LogD:  0.794
LogS:  -3.001
# Rotatable Bonds:  8
TPSA:  173.6
# H-Bond Aceptor:  12
# H-Bond Donor:  5
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.291
Synthetic Accessibility Score:  4.699
Fsp3:  0.625
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.947
MDCK Permeability:  7.982688839547336e-05
Pgp-inhibitor:  0.048
Pgp-substrate:  0.929
Human Intestinal Absorption (HIA):  0.85
20% Bioavailability (F20%):  0.013
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.215
Plasma Protein Binding (PPB):  33.05801010131836%
Volume Distribution (VD):  0.41
Pgp-substrate:  27.560096740722656%

ADMET: Metabolism

CYP1A2-inhibitor:  0.019
CYP1A2-substrate:  0.388
CYP2C19-inhibitor:  0.016
CYP2C19-substrate:  0.716
CYP2C9-inhibitor:  0.003
CYP2C9-substrate:  0.079
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.142
CYP3A4-inhibitor:  0.044
CYP3A4-substrate:  0.122

ADMET: Excretion

Clearance (CL):  2.725
Half-life (T1/2):  0.887

ADMET: Toxicity

hERG Blockers:  0.189
Human Hepatotoxicity (H-HT):  0.19
Drug-inuced Liver Injury (DILI):  0.146
AMES Toxicity:  0.063
Rat Oral Acute Toxicity:  0.02
Maximum Recommended Daily Dose:  0.1
Skin Sensitization:  0.077
Carcinogencity:  0.875
Eye Corrosion:  0.003
Eye Irritation:  0.018
Respiratory Toxicity:  0.48

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474936

Natural Product ID:  NPC474936
Common Name*:   6-O-3',4'-Dimethoxybenzoyl Ajugol
IUPAC Name:   [(2R,3S,4S,5R,6S)-6-[[(1S,4aR,5R,7S,7aS)-5,7-dihydroxy-7-methyl-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-1-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4-dimethoxybenzoate
Synonyms:  
Standard InCHIKey:  MHLBJQVZNLCHBZ-NPWFAMOPSA-N
Standard InCHI:  InChI=1S/C24H32O12/c1-24(30)9-13(25)12-6-7-33-22(17(12)24)36-23-20(28)19(27)18(26)16(35-23)10-34-21(29)11-4-5-14(31-2)15(8-11)32-3/h4-8,12-13,16-20,22-23,25-28,30H,9-10H2,1-3H3/t12-,13+,16+,17+,18+,19-,20+,22-,23-,24-/m0/s1
SMILES:  COc1cc(ccc1OC)C(=O)OC[C@H]1O[C@@H](O[C@@H]2OC=C[C@@H]3[C@H]2[C@@](C)(O)C[C@H]3O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL488723
PubChem CID:   44575706
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14242 Maytenus laevis Species Celastraceae Eukaryota bark Leticia, Colombia n.a. PMID[15568791]
NPO14242 Maytenus laevis Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT927 Cell Line PBMC Homo sapiens Activity = 12.6 pg/ml PMID[564015]
NPT927 Cell Line PBMC Homo sapiens Activity = 27.2 pg/ml PMID[564015]
NPT927 Cell Line PBMC Homo sapiens Activity = 38.1 pg/ml PMID[564015]
NPT927 Cell Line PBMC Homo sapiens Activity = 849.5 pg/ml PMID[564015]
NPT927 Cell Line PBMC Homo sapiens Activity < 7.8 pg/ml PMID[564015]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474936 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.974 High Similarity NPC206815
0.974 High Similarity NPC476011
0.9679 High Similarity NPC282551
0.9554 High Similarity NPC130730
0.9554 High Similarity NPC301910
0.9437 High Similarity NPC470685
0.9313 High Similarity NPC21956
0.9295 High Similarity NPC179914
0.9286 High Similarity NPC478232
0.9272 High Similarity NPC308178
0.9236 High Similarity NPC138993
0.915 High Similarity NPC147224
0.9091 High Similarity NPC475379
0.9091 High Similarity NPC269914
0.9091 High Similarity NPC478249
0.9085 High Similarity NPC478234
0.9085 High Similarity NPC478236
0.9062 High Similarity NPC109990
0.9032 High Similarity NPC203664
0.9 High Similarity NPC145847
0.8987 High Similarity NPC226759
0.8981 High Similarity NPC475484
0.8968 High Similarity NPC289021
0.8968 High Similarity NPC158546
0.8954 High Similarity NPC473149
0.891 High Similarity NPC194705
0.891 High Similarity NPC36130
0.891 High Similarity NPC134905
0.8903 High Similarity NPC240592
0.8903 High Similarity NPC117346
0.8889 High Similarity NPC180586
0.8868 High Similarity NPC187205
0.8854 High Similarity NPC89693
0.8854 High Similarity NPC229548
0.8854 High Similarity NPC137813
0.8854 High Similarity NPC478241
0.8812 High Similarity NPC469384
0.8797 High Similarity NPC191046
0.8797 High Similarity NPC194095
0.8797 High Similarity NPC327032
0.8782 High Similarity NPC227980
0.875 High Similarity NPC286919
0.875 High Similarity NPC475663
0.8742 High Similarity NPC10205
0.8718 High Similarity NPC111785
0.8718 High Similarity NPC96599
0.8713 High Similarity NPC96194
0.8713 High Similarity NPC299855
0.8693 High Similarity NPC302286
0.8693 High Similarity NPC237872
0.8693 High Similarity NPC88754
0.8693 High Similarity NPC263397
0.8693 High Similarity NPC116104
0.8693 High Similarity NPC475213
0.8693 High Similarity NPC152796
0.8688 High Similarity NPC471405
0.8688 High Similarity NPC478248
0.8671 High Similarity NPC478235
0.8663 High Similarity NPC189704
0.865 High Similarity NPC41009
0.8645 High Similarity NPC473867
0.8642 High Similarity NPC478265
0.8636 High Similarity NPC77922
0.8636 High Similarity NPC473281
0.8636 High Similarity NPC478240
0.8634 High Similarity NPC472860
0.8634 High Similarity NPC133984
0.8616 High Similarity NPC229354
0.8613 High Similarity NPC476067
0.8613 High Similarity NPC475121
0.8599 High Similarity NPC478242
0.8596 High Similarity NPC473205
0.8596 High Similarity NPC473776
0.858 High Similarity NPC160780
0.858 High Similarity NPC289811
0.8571 High Similarity NPC242756
0.8553 High Similarity NPC289438
0.8544 High Similarity NPC229882
0.8544 High Similarity NPC158635
0.8544 High Similarity NPC205054
0.8528 High Similarity NPC203020
0.8528 High Similarity NPC239966
0.8526 High Similarity NPC37838
0.8519 High Similarity NPC104275
0.8519 High Similarity NPC4747
0.8519 High Similarity NPC49173
0.8519 High Similarity NPC1913
0.8516 High Similarity NPC296659
0.8516 High Similarity NPC202391
0.8509 High Similarity NPC172920
0.8509 High Similarity NPC156624
0.85 High Similarity NPC310661
0.85 High Similarity NPC105827
0.85 High Similarity NPC157898
0.8485 Intermediate Similarity NPC100420
0.8476 Intermediate Similarity NPC472859
0.8476 Intermediate Similarity NPC311803
0.8476 Intermediate Similarity NPC25389
0.8471 Intermediate Similarity NPC18789
0.8466 Intermediate Similarity NPC76211
0.8466 Intermediate Similarity NPC475299
0.8462 Intermediate Similarity NPC195972
0.8462 Intermediate Similarity NPC316539
0.8457 Intermediate Similarity NPC71385
0.8457 Intermediate Similarity NPC230670
0.8457 Intermediate Similarity NPC475378
0.8447 Intermediate Similarity NPC476364
0.8442 Intermediate Similarity NPC80098
0.8434 Intermediate Similarity NPC475738
0.8428 Intermediate Similarity NPC69367
0.8424 Intermediate Similarity NPC33298
0.8424 Intermediate Similarity NPC285108
0.8415 Intermediate Similarity NPC119125
0.8415 Intermediate Similarity NPC166277
0.8412 Intermediate Similarity NPC469354
0.8412 Intermediate Similarity NPC469438
0.8412 Intermediate Similarity NPC169645
0.8412 Intermediate Similarity NPC84482
0.8409 Intermediate Similarity NPC112708
0.8408 Intermediate Similarity NPC474234
0.8397 Intermediate Similarity NPC184464
0.8397 Intermediate Similarity NPC251062
0.8395 Intermediate Similarity NPC38699
0.8385 Intermediate Similarity NPC245615
0.8385 Intermediate Similarity NPC61604
0.8385 Intermediate Similarity NPC299706
0.8385 Intermediate Similarity NPC44730
0.8385 Intermediate Similarity NPC115466
0.8365 Intermediate Similarity NPC98809
0.8365 Intermediate Similarity NPC476394
0.8362 Intermediate Similarity NPC473711
0.8354 Intermediate Similarity NPC74319
0.8354 Intermediate Similarity NPC287872
0.8344 Intermediate Similarity NPC478266
0.8344 Intermediate Similarity NPC163635
0.8333 Intermediate Similarity NPC208818
0.8333 Intermediate Similarity NPC472128
0.8333 Intermediate Similarity NPC186296
0.8333 Intermediate Similarity NPC472127
0.8324 Intermediate Similarity NPC188217
0.8323 Intermediate Similarity NPC472130
0.8323 Intermediate Similarity NPC472131
0.8323 Intermediate Similarity NPC267091
0.8313 Intermediate Similarity NPC246024
0.8313 Intermediate Similarity NPC148273
0.8312 Intermediate Similarity NPC31745
0.8312 Intermediate Similarity NPC49597
0.8312 Intermediate Similarity NPC220936
0.8303 Intermediate Similarity NPC289346
0.8303 Intermediate Similarity NPC239818
0.8303 Intermediate Similarity NPC218471
0.8303 Intermediate Similarity NPC476337
0.8302 Intermediate Similarity NPC472969
0.8284 Intermediate Similarity NPC197708
0.8284 Intermediate Similarity NPC658
0.828 Intermediate Similarity NPC110063
0.828 Intermediate Similarity NPC471028
0.828 Intermediate Similarity NPC473090
0.8274 Intermediate Similarity NPC476277
0.8272 Intermediate Similarity NPC308555
0.8269 Intermediate Similarity NPC296643
0.8263 Intermediate Similarity NPC100425
0.8263 Intermediate Similarity NPC120012
0.8261 Intermediate Similarity NPC474620
0.8261 Intermediate Similarity NPC243891
0.8261 Intermediate Similarity NPC140151
0.825 Intermediate Similarity NPC161955
0.825 Intermediate Similarity NPC92117
0.8246 Intermediate Similarity NPC163165
0.8242 Intermediate Similarity NPC469654
0.8239 Intermediate Similarity NPC476338
0.8239 Intermediate Similarity NPC24257
0.8239 Intermediate Similarity NPC476359
0.8239 Intermediate Similarity NPC153620
0.8235 Intermediate Similarity NPC43434
0.8235 Intermediate Similarity NPC472129
0.8228 Intermediate Similarity NPC108455
0.8228 Intermediate Similarity NPC469683
0.8225 Intermediate Similarity NPC116745
0.8217 Intermediate Similarity NPC478250
0.821 Intermediate Similarity NPC228662
0.8205 Intermediate Similarity NPC137501
0.8205 Intermediate Similarity NPC46644
0.8205 Intermediate Similarity NPC154262
0.8205 Intermediate Similarity NPC79908
0.8205 Intermediate Similarity NPC159387
0.8205 Intermediate Similarity NPC7518
0.8204 Intermediate Similarity NPC90905
0.8204 Intermediate Similarity NPC4013
0.8199 Intermediate Similarity NPC473091
0.8199 Intermediate Similarity NPC182350
0.8198 Intermediate Similarity NPC107739
0.8194 Intermediate Similarity NPC226005
0.8193 Intermediate Similarity NPC208676
0.8193 Intermediate Similarity NPC130489
0.8187 Intermediate Similarity NPC120621
0.8187 Intermediate Similarity NPC5786
0.8187 Intermediate Similarity NPC248257
0.8187 Intermediate Similarity NPC102851
0.8187 Intermediate Similarity NPC189631

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474936 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9379 High Similarity NPD7685 Pre-registration
0.8057 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD3818 Discontinued
0.7965 Intermediate Similarity NPD7054 Approved
0.7929 Intermediate Similarity NPD7199 Phase 2
0.7919 Intermediate Similarity NPD7472 Approved
0.7888 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7886 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7816 Intermediate Similarity NPD7074 Phase 3
0.7784 Intermediate Similarity NPD7808 Phase 3
0.7736 Intermediate Similarity NPD7266 Discontinued
0.7733 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD7251 Discontinued
0.7725 Intermediate Similarity NPD37 Approved
0.7701 Intermediate Similarity NPD7228 Approved
0.7697 Intermediate Similarity NPD1653 Approved
0.7692 Intermediate Similarity NPD4966 Approved
0.7692 Intermediate Similarity NPD4967 Phase 2
0.7692 Intermediate Similarity NPD4965 Approved
0.7692 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.767 Intermediate Similarity NPD6797 Phase 2
0.7654 Intermediate Similarity NPD6190 Approved
0.7647 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD3817 Phase 2
0.7616 Intermediate Similarity NPD8127 Discontinued
0.7602 Intermediate Similarity NPD6234 Discontinued
0.7593 Intermediate Similarity NPD4628 Phase 3
0.7532 Intermediate Similarity NPD230 Phase 1
0.7529 Intermediate Similarity NPD5353 Approved
0.7528 Intermediate Similarity NPD7240 Approved
0.75 Intermediate Similarity NPD7028 Phase 2
0.7484 Intermediate Similarity NPD6653 Approved
0.7458 Intermediate Similarity NPD5844 Phase 1
0.7446 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD1934 Approved
0.7372 Intermediate Similarity NPD9494 Approved
0.7368 Intermediate Similarity NPD8455 Phase 2
0.7368 Intermediate Similarity NPD2801 Approved
0.7365 Intermediate Similarity NPD6273 Approved
0.736 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD5494 Approved
0.7353 Intermediate Similarity NPD6385 Approved
0.7353 Intermediate Similarity NPD6386 Approved
0.7348 Intermediate Similarity NPD8313 Approved
0.7348 Intermediate Similarity NPD8312 Approved
0.7345 Intermediate Similarity NPD7473 Discontinued
0.7337 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6559 Discontinued
0.7294 Intermediate Similarity NPD4380 Phase 2
0.7288 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD6166 Phase 2
0.7283 Intermediate Similarity NPD3882 Suspended
0.7278 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6232 Discontinued
0.7267 Intermediate Similarity NPD7819 Suspended
0.7267 Intermediate Similarity NPD1465 Phase 2
0.7267 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD7075 Discontinued
0.7235 Intermediate Similarity NPD7458 Discontinued
0.7207 Intermediate Similarity NPD7799 Discontinued
0.7205 Intermediate Similarity NPD1933 Approved
0.7205 Intermediate Similarity NPD447 Suspended
0.7169 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD4110 Phase 3
0.7168 Intermediate Similarity NPD5761 Phase 2
0.7168 Intermediate Similarity NPD5760 Phase 2
0.7152 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD8434 Phase 2
0.7126 Intermediate Similarity NPD5402 Approved
0.711 Intermediate Similarity NPD6801 Discontinued
0.7108 Intermediate Similarity NPD6674 Discontinued
0.7101 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD6355 Discontinued
0.7097 Intermediate Similarity NPD3705 Approved
0.7091 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD5762 Approved
0.7091 Intermediate Similarity NPD6004 Phase 3
0.7091 Intermediate Similarity NPD5763 Approved
0.7091 Intermediate Similarity NPD6002 Phase 3
0.7091 Intermediate Similarity NPD6005 Phase 3
0.7091 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD5647 Approved
0.7077 Intermediate Similarity NPD7999 Approved
0.7066 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7435 Discontinued
0.7062 Intermediate Similarity NPD7497 Discontinued
0.7059 Intermediate Similarity NPD9545 Approved
0.7041 Intermediate Similarity NPD1511 Approved
0.7041 Intermediate Similarity NPD6799 Approved
0.7039 Intermediate Similarity NPD5242 Approved
0.7037 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD6362 Approved
0.7017 Intermediate Similarity NPD3751 Discontinued
0.7012 Intermediate Similarity NPD7097 Phase 1
0.7006 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.6983 Remote Similarity NPD3787 Discontinued
0.6982 Remote Similarity NPD7236 Approved
0.6981 Remote Similarity NPD6007 Clinical (unspecified phase)
0.697 Remote Similarity NPD7033 Discontinued
0.6965 Remote Similarity NPD7930 Approved
0.6959 Remote Similarity NPD1512 Approved
0.6957 Remote Similarity NPD6765 Approved
0.6957 Remote Similarity NPD6764 Approved
0.6943 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6943 Remote Similarity NPD1608 Approved
0.6932 Remote Similarity NPD5978 Approved
0.6932 Remote Similarity NPD5977 Approved
0.6919 Remote Similarity NPD5403 Approved
0.6914 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6914 Remote Similarity NPD3764 Approved
0.691 Remote Similarity NPD919 Approved
0.6907 Remote Similarity NPD6781 Approved
0.6907 Remote Similarity NPD6778 Approved
0.6907 Remote Similarity NPD6782 Approved
0.6907 Remote Similarity NPD6780 Approved
0.6907 Remote Similarity NPD6777 Approved
0.6907 Remote Similarity NPD6776 Approved
0.6907 Remote Similarity NPD6779 Approved
0.6903 Remote Similarity NPD1357 Approved
0.6901 Remote Similarity NPD2532 Approved
0.6901 Remote Similarity NPD2533 Approved
0.6901 Remote Similarity NPD2534 Approved
0.6901 Remote Similarity NPD5401 Approved
0.6899 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6897 Remote Similarity NPD6599 Discontinued
0.6888 Remote Similarity NPD7680 Approved
0.6884 Remote Similarity NPD8151 Discontinued
0.6879 Remote Similarity NPD7239 Suspended
0.6879 Remote Similarity NPD1091 Approved
0.6871 Remote Similarity NPD6233 Phase 2
0.6865 Remote Similarity NPD7038 Approved
0.6865 Remote Similarity NPD7039 Approved
0.6864 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6862 Remote Similarity NPD8150 Discontinued
0.6857 Remote Similarity NPD7411 Suspended
0.6852 Remote Similarity NPD3027 Phase 3
0.685 Remote Similarity NPD7875 Clinical (unspecified phase)
0.685 Remote Similarity NPD7874 Approved
0.6845 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6836 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6835 Remote Similarity NPD9269 Phase 2
0.6829 Remote Similarity NPD3620 Phase 2
0.6829 Remote Similarity NPD4140 Approved
0.6829 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6826 Remote Similarity NPD2796 Approved
0.6826 Remote Similarity NPD2935 Discontinued
0.6816 Remote Similarity NPD7783 Phase 2
0.6816 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6809 Remote Similarity NPD6785 Approved
0.6809 Remote Similarity NPD6784 Approved
0.6806 Remote Similarity NPD7296 Approved
0.6802 Remote Similarity NPD7697 Approved
0.6802 Remote Similarity NPD7696 Phase 3
0.6802 Remote Similarity NPD7698 Approved
0.6795 Remote Similarity NPD9268 Approved
0.6784 Remote Similarity NPD7583 Approved
0.6774 Remote Similarity NPD5536 Phase 2
0.677 Remote Similarity NPD2798 Approved
0.6768 Remote Similarity NPD8319 Approved
0.6768 Remote Similarity NPD8320 Phase 1
0.6768 Remote Similarity NPD7871 Phase 2
0.6768 Remote Similarity NPD7870 Phase 2
0.6766 Remote Similarity NPD1510 Phase 2
0.6766 Remote Similarity NPD2799 Discontinued
0.6765 Remote Similarity NPD8166 Discontinued
0.6765 Remote Similarity NPD3750 Approved
0.6758 Remote Similarity NPD3926 Phase 2
0.6752 Remote Similarity NPD17 Approved
0.6751 Remote Similarity NPD6823 Phase 2
0.675 Remote Similarity NPD7701 Phase 2
0.675 Remote Similarity NPD1876 Approved
0.675 Remote Similarity NPD7585 Approved
0.6748 Remote Similarity NPD7095 Approved
0.6746 Remote Similarity NPD1549 Phase 2
0.6743 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6743 Remote Similarity NPD3226 Approved
0.674 Remote Similarity NPD1247 Approved
0.6733 Remote Similarity NPD7801 Approved
0.6726 Remote Similarity NPD2438 Suspended
0.6718 Remote Similarity NPD4420 Approved
0.6707 Remote Similarity NPD6798 Discontinued
0.6706 Remote Similarity NPD1652 Phase 2
0.6705 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6705 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6705 Remote Similarity NPD3146 Approved
0.6705 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6703 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6699 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6687 Remote Similarity NPD6832 Phase 2
0.6687 Remote Similarity NPD5735 Approved
0.6686 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6686 Remote Similarity NPD2346 Discontinued
0.6686 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3748 Approved
0.6667 Remote Similarity NPD6663 Approved
0.6667 Remote Similarity NPD3749 Approved
0.6667 Remote Similarity NPD6873 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data